David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$826M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
Pinduoduo
PDD
|
+$305M |
| 4 |
Intel
INTC
|
+$274M |
| 5 |
Apple
AAPL
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$382M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$298M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$267M |
| 4 |
Procter & Gamble
PG
|
+$260M |
| 5 |
Meta Platforms (Facebook)
META
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.35% |
| 2 | Healthcare | 8.99% |
| 3 | Financials | 7.94% |
| 4 | Consumer Discretionary | 7.49% |
| 5 | Industrials | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLVR
901
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
| $18.2M | 0.02% |
1,815,000
| – | – |
|
902
Constellium
CSTM
$3.61B
| $18.1M | 0.02% |
1,533,291
+117,742
| +8% | +$1.38M |
|
903
CALL
Teladoc Health
TDOC
$1.13B
| $18.1M | 0.02% |
766,500
-82,700
| -10% | -$2.23M |
|
904
CALL
Boston Beer
SAM
$1.95B
| $18.1M | 0.02% |
54,800
+5,400
| +11% | +$1.96M |
|
905
CALL
Seagate
STX
$180B
| $18M | 0.02% |
342,900
+179,300
| +110% | +$9.53M |
|
906
PUT
Accenture
ACN
$114B
| $18M | 0.02% |
67,500
+14,600
| +28% | +$4.04M |
|
907
Oceaneering
OII
$5.02B
| $18M | 0.02% |
1,029,440
+7,198
| +0.7% | +$95.7K |
|
908
Clean Energy Fuels
CLNE
$351M
| $18M | 0.02% |
3,462,164
-430,423
| -11% | -$2.64M |
|
909
Veeco
VECO
$2.86B
| $18M | 0.02% |
968,020
+98,438
| +11% | +$1.85M |
|
910
PUT
Atlassian
TEAM
$43.4B
| $18M | 0.02% |
139,500
-74,800
| -35% | -$11.9M |
|
911
PUT
DuPont de Nemours
DD
$18.5B
| $17.9M | 0.02% |
208,328
+55,288
| +36% | +$4.42M |
|
912
Occidental Petroleum Corp Warrants
OXY.WS
$35.9B
| $17.8M | 0.02% |
432,461
| – | – |
|
|
SIVB
913
PUT
DELISTED
SVB Financial Group
SIVB
| $17.8M | 0.02% |
77,300
+27,100
| +54% | +$6.73M |
|
914
Thomson Reuters
TRI
$47.1B
| $17.7M | 0.02% |
147,596
-33,787
| -19% | -$3.89M |
|
915
PUT
CVS Health
CVS
$120B
| $17.7M | 0.02% |
190,000
-46,700
| -20% | -$4.51M |
|
916
StoneCo
STNE
$2.2B
| $17.7M | 0.02% |
1,872,143
+590,710
| +46% | +$6.19M |
|
917
Theravance Biopharma
TBPH
$883M
| $17.6M | 0.02% |
1,572,650
-14,548
| -0.9% | -$153K |
|
|
HOUS
918
DELISTED
Anywhere Real Estate
HOUS
| $17.6M | 0.02% |
2,757,202
+582,423
| +27% | +$4.21M |
|
|
PACW
919
DELISTED
PacWest Bancorp
PACW
| $17.6M | 0.02% |
767,320
-75,240
| -9% | -$1.82M |
|
920
Borealis Foods
BRLS
$37.8M
| $17.6M | 0.02% |
1,704,487
+40,000
| +2% | +$408K |
|
921
RTX Corp
RTX
$282B
| $17.6M | 0.02% |
174,398
-1,624,277
| -90% | -$153M |
|
922
PUT
Enbridge
ENB
$109B
| $17.6M | 0.02% |
450,000
-40,000
| -8% | -$1.56M |
|
923
PUT
Cenovus Energy
CVE
$59.3B
| $17.6M | 0.02% |
905,000
+150,000
| +20% | +$2.88M |
|
924
Qualys
QLYS
$6.17B
| $17.5M | 0.02% |
156,296
+126,283
| +421% | +$15.8M |
|
925
Neogen
NEOG
$2.53B
| $17.5M | 0.02% |
1,151,622
-36,872
| -3% | -$525K |
|
Similar funds
David Shaw's Q4 2022 Portfolio in Review
As of Q4 2022, David Shaw held 5,609 positions worth $90.5B, up 8.1% from $83.7B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
David Shaw's Q4 2022 filing shows 475 new, 1,793 increased, 1,541 reduced and 783 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M. The largest sale was Berkshire Hathaway Class B, an estimated $382M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- David Shaw's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 3,017,047 shares worth $255M.
- David Shaw added most to Tesla in Q4 2022, an estimated $826M increase.
- David Shaw's biggest Q4 2022 reduction was Berkshire Hathaway Class B, cutting an estimated $382M.
- David Shaw fully exited Twitter, Inc. in Q4 2022, selling an estimated $267M.
- David Shaw's ten largest holdings make up 8.3% of its $90.5B portfolio in Q4 2022.
- David Shaw opened 475 new positions and closed 783 in Q4 2022.
- David Shaw's portfolio value rose 8.1% quarter-over-quarter to $90.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.